Companhia Brasileira de Distribuicao (NYSE:CBD) was up 5.5% during trading on Tuesday . The company traded as high as $15.80 and last traded at $15.73, with a volume of 963,685 shares. The stock had previously closed at $14.91.

A number of equities research analysts have recently commented on CBD shares. Deutsche Bank AG upgraded Companhia Brasileira de Distribuicao from a “hold” rating to a “buy” rating in a research note on Tuesday, June 7th. Zacks Investment Research upgraded Companhia Brasileira de Distribuicao from a “sell” rating to a “hold” rating in a research note on Tuesday, June 14th. One analyst has rated the stock with a sell rating, five have issued a hold rating and one has issued a buy rating to the company. The stock presently has a consensus rating of “Hold” and an average target price of $10.17.

The stock has a market cap of $4.34 billion and a price-to-earnings ratio of 58.36. The stock’s 50 day moving average price is $13.08 and its 200 day moving average price is $12.17.

A hedge fund recently raised its stake in Companhia Brasileira de Distribuicao stock. Brandes Investment Partners LP increased its stake in Companhia Brasileira de Distribuicao (NYSE:CBD) by 5.5% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 2,095,051 shares of the company’s stock after buying an additional 110,038 shares during the period. Brandes Investment Partners LP owned 0.79% of Companhia Brasileira de Distribuicao worth $22,040,000 as of its most recent SEC filing.

Companhia Brasileira de Distribuicao, directly or through its subsidiaries, is engaged in the retail of food, clothing, home appliances, electronics and other items through its chain of hypermarkets, supermarkets, specialized stores and department stores. The Company’s operating segments include Retail segment, Cash and carry segment, Home appliances segment and E-commerce segment.

Get Analysts' Upgrades and Downgrades Daily - Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.